Mn complex-mediated enhancement of antitumor response through modulating myeloid-derived suppressor cells in

Satyajit Das1, Kaushik Banerjee1, Susmita Roy2

  • 1Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, Kolkata, India.

In Vivo (Athens, Greece)
|September 6, 2014
PubMed
Abstract

Insights

Mn-N-(2-hydroxyacetophenone) glycinate (MnNG) enhances anti-tumor immunity by modulating the tumor microenvironment. It reduces suppressive myeloid-derived suppressor cells and promotes T-helper 1 cell responses, improving cancer therapy efficacy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Pharmacology

Background:

  • The tumor microenvironment (TME) often confers resistance to chemotherapy.
  • Developing effective immunomodulators for cancer therapy remains a challenge.

Purpose of the Study:

  • To investigate the immunomodulatory effects of Mn-N-(2-hydroxyacetophenone) glycinate (MnNG) on the tumor microenvironment.
  • To assess MnNG's potential as an anti-cancer therapeutic agent.

Main Methods:

  • Assessed myeloid-derived suppressor cells (MDSCs) and Cluster of Differentiation 4 (Cd4)(+) T-cells (secreting Interferon-γ [Ifnγ] and Interleukin-4 [Il4]) using annexin V-binding assay.
  • Evaluated T-cell proliferation via in vitro co-culture assay and flow cytometry in a drug-resistant TME.
  • Analyzed MDSC differentiation, co-stimulatory molecule expression, and T-helper cell 1 (Th1) response.

Main Results:

  • MnNG treatment increased Ifnγ-secreting Cd4(+) T-cell infiltration and decreased MDSC numbers in vivo.
  • MnNG modulated MDSC differentiation into dendritic cells, up-regulating co-stimulatory molecules and reversing MDSC suppressive functions.
  • Co-culture of Cd4(+) T-cells with MDSCs showed reduced Il4 and enhanced Ifnγ expression after MnNG treatment.

Conclusions:

  • MnNG effectively modulates MDSC differentiation towards dendritic cells within the drug-resistant TME.
  • MnNG enhances the T-helper cell 1 (Th1) immune response, demonstrating significant immunomodulatory efficacy.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K